Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cosentyx
Pharma
Novartis' Cosentyx clinches FDA nod in lesser-known skin disease
Cosentyx may soon share the hidradenitis suppurativa field with another inflammatory biologic—but, for now, the Novartis drug has a head start.
Fraiser Kansteiner
Nov 1, 2023 9:45am
Novartis shines a light on HS at the Tribeca Festival
Jun 8, 2023 7:50am
Novartis, UCB set to battle it out in inflammatory skin disease
Apr 10, 2023 4:40pm
AbbVie's Skyrizi clears psoriasis where Cosentyx, Taltz couldn't
Mar 18, 2023 10:00am
Novartis delays Pluvicto filing after FDA requests more data
Feb 1, 2023 11:19am
Novartis ties HQ raid to Cosentyx patent fight against Lilly
Oct 25, 2022 11:24am